1,3,8-triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders
US7053101B2 · kind B2 · utility
6Cited by
13References
8Claims
0Family size
Inventors
Key dates
| Filing date | Aug 2, 2004 |
| Grant date | May 30, 2006 |
| Priority date | — |
| Expiry date | Dec 16, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel 1,3,8-triazaspiro[4.5]decan-4-one derivatives of the general formula
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.